Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.90 | N/A | -8.44% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.90 | N/A | -8.44% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about ongoing market pressures. They highlighted the importance of adapting strategies to navigate these challenges.
Management noted challenges in the current market environment.
They emphasized the need for strategic adjustments moving forward.
The earnings report indicates that Prestige Consumer faced challenges, leading to an EPS miss. The stock reacted negatively, dropping 10.05%, reflecting investor concerns about the company's performance and future outlook. Without revenue figures or updated guidance, uncertainty remains about the company's direction in the upcoming quarters.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SIMON PPTY GROUP INC REIT
Aug 4, 2025